Variables | 2002–2006 | 2007–2011 | ||
---|---|---|---|---|
OR (95 % CI) | OR (95 % CI) | |||
Anti-TNF vs Non-users | DMARDs vs Non-users | Anti-TNF vs Non-users | DMARDs vs Non-users | |
Demographics | ||||
Residence (rural vs urbain) | 1.21 (0.88, 1.66) | 1.05 (0.81, 1.38) | 1.43 (1.05, 1.96) | 1.15 (0.87, 1.51) |
Higher income | 1.14 (0.90, 1.46) | 1.02 (0.83, 1.26) | 0.76 (0.59, 0.98) | 0.70 (0.56, 0.87) |
Socioeconomic status | ||||
Social quintile 0 | 1.02 (0.62, 1.68) | 0.75 (0.48, 1.17) | 1.33 (0.73, 2.41) | 1.00 (0.59, 1.71) |
Social quintile 2–3 versus 1 | 0.69 (0.48, 0.98) | 0.69 (0.51, 0.93) | 0.71 (0.49, 1.01) | 0.72 (0.53, 0.98) |
Social quintile 4–5 versus 1 | 0.61 (0.43, 0.88) | 0.66 (0.49, 0.90) | 0.82 (0.57, 1.18) | 0.74 (0.54, 1.01) |
Use of health services in prior year | ||||
Visit to rheumatologist | 2.73 (1.97, 3.79) | 1.74 (1.36, 2.22) | 4.41 (3.27, 5.95) | 2.86 (2.29, 3.60) |
Comorbidity in prior year | ||||
Hematologic disorders | 1.32 (0.90, 1.94) | 0.92 (0.66, 1.28) | 0.88 (0.60, 1.30) | 0.96 (0.69, 1.32) |
Heart failure | 1.97 (0.84, 4.61) | 1.95 (0.89, 4.29) | 0.82 (0.41, 1.63) | 0.52 (0.28, 0.94) |
Cerebrovascular disease | 1.43 (0.74, 2.75) | 0.75 (0.39, 1.42) | 0.38 (0.16, 0.86) | 0.63 (0.35, 1.14) |
Ischemic heart disease | 1.06 (0.72, 1.55) | 0.90 (0.64, 1.26) | 0.97 (0.63, 1.50) | 1.33 (0.93, 1.91) |
Cancer | 0.86 (0.55, 1.35) | 1.17 (0.81, 1.69) | 0.82 (0.56, 1.20) | 0.88 (0.64, 1.22) |
Medication use in prior year | ||||
NSAIDs | 1.59 (1.21, 2.09) | 1.26 (1.02, 1.58) | 1.87 (1.46, 2.40) | 1.66 (1.35, 2.05) |
Serotonin reuptake inhibitors | 0.93 (0.62, 1.39) | 0.90 (0.65, 1.26) | 1.08 (0.72, 1.63) | 1.12 (0.79, 1.60) |
Gastroprotective agents | 1.04 (0.81, 1.33) | 1.18 (0.95, 1.45) | 1.09 (0.84, 1.42) | 0.85 (0.68, 1.06) |
Antidiabetics | 1.39 (0.93, 2.08) | 1.28 (0.89, 1.83) | 0.76 (0.52, 1.09) | 0.71 (0.53, 0.97) |
Corticosteroid | 1.87 (1.44, 2.43) | 1.22 (0.99, 1.50) | 1.92 (1.49, 2.47) | 0.96 (0.78, 1.18) |
Anticoagulants | 0.90 (0.50, 1.62) | 0.84 (0.52, 1.37) | 0.98 (0.56, 1.71) | 1.39 (0.89, 2.19) |
Antihypertensives | 1.21 (0.94, 1.57) | 1.20 (0.97, 1.48) | 0.93 (0.72, 1.21) | 0.85 (0.68, 1.06) |